IND for One Patient to Receive Clofazamine for Treatment of MAI

Yale University0 个研究点目标入组 1 人开始时间: 2006年5月最近更新: 2008年4月3日

研究概览

简要总结

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

研究设计

研究类型: Observational

入排标准

性别: Female
接受健康志愿者: 否

入选标准

•Treatment of one patient with MAI

排除标准

•No other patients will be treated

研究者

发起方

Yale University

申办方类型

Other

相似试验

No Longer Available

不适用

A Single Patient IND for PD-0325901Prior Treatment With PD-0325901 With Ongoing Clinical Response

NCT02297802Sharp HealthCare

Unknown

不适用

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Multiple Myeloma

NCT05503550Janssen Research & Development, LLC

No Longer Available

不适用

Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple MyelomaMultiple Myeloma

NCT02541643Sundar Jagannath

Available

不适用

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)Metastatic Castration-Resistant Prostate Cancer

NCT05650476Pfizer

已完成

1 期

Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult SubjectsHealthy

NCT00867880Cumberland Pharmaceuticals12